SkyCell, which is headquartered in both Zug and Technopark Zurich in Switzerland, has secured fresh capital of 116 million US dollars in a Series D financing round. This investment will be put towards expanding the company’s global presence, according to a press release. SkyCell’s primary focus will now be on securing growth in connection with its temperature-controlled, door-to-door air freight containers for sensitive pharmaceutical products across North and South America, EMEA and Asia.
These expansion plans are being supported by two new investors. Tybourne Capital, headquartered in Hong Kong, manages long-term capital on behalf of prominent non-profit organizations, foundations and pension funds. CCI, a Chicago-based subsidiary of Henry Crown and Company, invests in growth companies focused on ecological sustainability.
“Having built the technological foundations in cold chain hardware and software/IoT-enabled tracking, this investment enables us to commercialize our platform into adjacent pharma market segments, significantly expanding our total addressable market beyond cold chain packaging”, comments Skycell CFO Dr. Remo Gerber in the press release.
According to information from CEO and co-founder Richard Ettl, the latest reuseable container saves an average of 50 percent CO2, or in absolute figures, 8 tons of CO2 per use. He goes on to state that digitalization is finally set to arrive in pharma supply chains. “Combined with the power of AI, this enables significant reductions in both cost and risk for our customers. With this new investment, we can further optimize supply chains and create truly sustainable logistics”. ce/mm
Related news
Meet with an expansion expert
Our services are free of charge and include:
- Introduction to key contacts in industry, academia, and government
- Advice on regulatory framework, taxes, labor, market, and setting up a company
- Custom-made fact-finding visits, including office and co-working space